Funding

Application Deadline: 4 September 2025 The MRC is looking to provide funding to support a programme of research focused on infections and immunity. The Infections and Immunity Board (IIB) aims to develop scientific knowledge that extends our understanding of human infectious disease and the role of the immune system in inflammation, immune-mediated disease, and cancer. This includes research into human pathogens and their mechanisms of infection, diseases of the human immune system, and conditions where altered immune regulation leads to pathology. The board seeks to support a diverse portfolio of research that is relevant to the UK and the wider world and spans the full remit of the Board, addressing established questions and areas while catalysing investigation of emergent opportunities. Research we fund includes discovery research relating to the following areas: human pathogens immune-mediated disease and multimorbidity immunology and inflammation antimicrobial resistance chronic Infections co-infection epidemiology and transmission vaccines biomarkers and diagnostics therapeutics The MRC is looking to fund a programme as a coordinated and coherent group of related projects. You may develop these projects to address an interrelated set of questions across a broad research area.

NOTE: 2025 application cycle is closed. Check the website again for 2026 updates. This track will aim to strengthen prevention, preparedness and response capacities in the face of future health crises, focusing on the priority emerging infectious diseases identified in the 2024 call: respiratory viruses, viral haemorrhagic fevers and arboviruses. The expected projects should adopt an interdisciplinary approach and contribute to advancing research in the service of public health. This call for proposals targets the three founding strands of the PEPR MIE: Section 1: Accelerating the acquisition of fundamental knowledge on emerging infectious diseases Section 2: Promoting innovation and developing new treatments, vaccines and other prevention, diagnostic and surveillance tools for emerging infectious diseases Section 3: Enabling public policies and society to cope with epidemic crises

The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions. Please refer to the websites for various funding opportunities and key dates for application.

Deadline to submit LOI is September 18, 2025.Refer to the website for other key dates. The Emerging Respiratory Pathogen Award was created to gain a better understanding of the pathobiology and the long term and immediate implications of respiratory infections. This includes emerging problems in known organisms and new and emerging pathogens. The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions: • A new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention • Understanding host factors that alter response to these infections • Understanding individual, regional, or social factors increasing or decreasing community spread of respiratory viruses • Case tracking and epidemiological approaches to understanding emerging respiratory viruses • The pathophysiology of the long term sequalae of respiratory viral infections, including COVID-19 • Key takeaways and lessons learned from the COVID-19 pandemic

European Respiratory Society (ERS) Long-Term Research Fellowships support researchers and clinicians in the early stages of their careers to carry out basic, translational or clinical research projects lasting between 6–24 months. Fellowship recipients conduct projects at research institutions outside of their home country, enabling fellows to access and learn research techniques that are not available at their home institutions. Long-term fellowships are awarded annually based on scientific merit as well as the skills and experience that fellows can bring to the host institution.

A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 22 affiliated international sites across 18 countries. UCGHI manages and supports the GloCal Health Fellowship.

The call for projects is open to any French research laboratory, whether public or private, contributing to public service missions of higher education and research. The proposed research projects can be presented in the form of a partnership between several French or international research teams, but the research team must be attached to a French research institution. Research grants for the completion of a thesis or a postdoctorate are also eligible. These grants may be associated with research projects filed on call or independent. They may be non-nominative at the time of filing the file. Applicants for these grants must be attached to a French research structure. The ANRS MIE encourages research that is as one of the research priorities targeted on the following themes: - The prevention of vertical transmission of HIV/AIDS, viral hepatitis, STIs and tuberculosis. - Screening, non-vaccine biomedical prevention and non-biomedical prevention of HIV/AIDS and sexually transmitted infections; - The cure (cure) of HIV/AIDS and HBV and HDV infections; - New therapeutic approaches for tuberculosis; - Issues of implementation and scaling of interventions. The selection procedures and criteria for projects, initiation contracts and research grants are detailed in the call regulations Opening: June 16, 2025 Closing: September 15, 2025 Communication of results: December 2025

The call for conference projects and publications covers all the thematic fields of the agency: - All research on HIV/AIDS, sexually transmitted infections (STIs), viral hepatitis, tuberculosis, including research on their co-infections; - Research on emerging and re-emerging infectious diseases, including arboviruses, respiratory viruses and viral hemorrhagic fevers. It is now possible to submit an application for funding continuously throughout the year, according to the following forecast schedule: January 15 – April 30 May 1 – August 31 September 1 – December 15

The ANRS Emerging Infectious Diseases, an autonomous agency of Inserm, supports research to provide scientific responses to infectious diseases in times of crisis and over the long term. It animates, coordinates, evaluates and finances research on HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases such as Covid-19, viral hemorrhagic fevers or arboviruses. It covers all areas of research: basic, translational and clinical research, research in public health and human and social sciences. The agency is developing a global health approach according to the One Health approach, which focuses on the links between human health, animal health and the environment. It thus strengthens France's response in the event of a crisis. The agency is part of an international effort to fight epidemics, in particular in close coordination with Europe and with a network of partners in low- and middle-income countries.

The Association of Public Health Labs and the US Centers for Disease Control and Prevention partner to offer paid laboratory internships to train and prepare college students for careers at public health laboratories. Interns join public health laboratory teams to make an impact on protecting the health of our communities. Interns assist laboratory professionals working on meaningful projects, including infectious diseases.

BWF’s financial support is channeled primarily through competitive peer-reviewed award programs. BWF makes grants primarily to degree-granting institutions on behalf of individual researchers. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science. Please refer to the website for upcoming funding deadlines.

Application Deadline: 7 October 2025 The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Please refer to the website for eligibility and details.

ERC Advanced Grants are designed to support excellent Principal Investigators at the career stage at which they are already established research leaders with a recognised track record of research achievements. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their research proposal. Please refer to the website for more information

E.W. "Al" Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority.​

Contact: Roger Ptak Roger.Ptak@nih.gov Objective: This new initiative aims to support investigator-led, multidisciplinary research to define how HIV-driven alterations to immunometabolism affect immune cell regulation, cell-cell interactions, response to treatment, and, ultimately, tuberculosis (TB) and hepatitis B virus (HBV) progression. Elucidating and subsequently probing such mechanisms will lead to identification of candidate biomarkers of disease progression and potential targets for immune-modulatory treatment (i.e., host-directed therapy) to decrease TB and HBV risk in people living with HIV. Description: This initiative will advance laboratory-based research to elucidate immunometabolic pathways and mechanisms that can be exploited for new therapeutic and diagnostic strategies.

The European Research Council (ERC) is a funding organisation for frontier research. It aims to stimulate scientific excellence in Europe by funding the very best, creative researchers of any nationality and age, and supporting their innovative ideas. Researchers from anywhere in the world can apply for ERC grants provided the research they undertake will be carried out in an EU Member State or Associated Country.

European Respiratory Society (ERS) fellowships offer funding and support for research projects that address unmet needs in respiratory science and medicine. The fellowship programmes seek to actively involve ERS members in the earlier phases of their careers, enabling the training and career development of the next generation of respiratory researchers and clinicians.

APPLICATION DEADLINE: 12 December 2025 This award from the ESPID enables members to attend scientific meetings, training events and courses, except for the annual ESPID meeting for which separate schemes are available. Awards are worth up to 1. EUR 1,000 for international travel outside of Europe ‚ 2. EUR 600 for travel within Europe and ‚ 3. EUR 200 for travel within the applicant’s own country. The awards also cover accommodation and registration fees.

APPLICATION DEADLINE: 31 October 2025 This recognises young investigators in the field of paediatric infectious diseases. Both clinical and basic research is eligible. The winner will receive: 1. Euro 5,000 to be paid to the host institution for research purposes only. The host institution is not allowed to take any overhead on this amount (see declaration below) 2. At the time of being offered the award successful candidates will be invited to attend that year's ESPID Annual Meeting with registration, travel and accommodation being offered (if already registered, this will be refunded). Please be aware the travel and accommodation are subject to ESPID Rules and maximum amounts apply 3. The Young Investigator's medal 4. The winner will be asked to give a 5 minute presentation of their work at the ESPID Annual Meeting

L’Initiative encourages the implementation of projects that involve national pandemic response programs, the research community, civil society, and the private sector. The main project initiator must be a legal entity with a board of directors/executive committee and head office registered in an eligible country or in France.

From 1995 to 2025, over 4 million dollars in grants have been awarded for community projects and clinical or basic science research projects related to tuberculosis (TB) and chronic pulmonary diseases in pediatric and adult populations. Project Visibility: - Presented at national and international conferences - Published in peer-reviewed journals - Highlighted in local news conferences - Impact - Projects have enhanced clinical teachings and patient care of TB through numerous routes:

Fogarty Funding Opportunities - Searchable Database

The Global Infectious Disease (GID) research training program addresses research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries. The training programs include a variety of research training options to match the needs of the developing country institution. Program focus on a major endemic or life-threatening emerging infectious disease, neglected tropical disease, infections that frequently occur as a co-infection in HIV infected individuals, or infections associated with noncommunicable disease conditions of public health importance in LMICs.

APPLICATION DEADLINE: 9 March, 2026 The International Research Scientist Development Award (IRSDA) provides support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience. The experience will be in a low- or middle-income country (LMIC) as defined by the World Bank . Low-income, lower-middle-income and upper-middle-income countries are included. Applications are invited from early career investigators from any health-related discipline who propose career development activities and a research project that is related to the health priorities of the LMIC.

Non-NIH Funding Opportunities - Grants and Fellowships - Searchable Database

This Fogarty International website offers news, resources, and funding opportunities for global health researchers focused on TB. It features recent scientific publications, information on grants, updates on drug-resistant TB and TB-HIV coinfection, and progress toward the development of new vaccines.

The Fulbright-Fogarty Fellowships in Public Health are offered through a partnership between the Fulbright Program and the Fogarty International Center of the U.S. National Institutes of Health. These awards were established to promote the expansion of research in public health and clinical research in resource-limited settings. The Fulbright-Fogarty Fellowships were inaugurated in July 2011 with four fellows in Sub-Saharan Africa (Botswana, Malawi, and South Africa). Approximately 10 awards are made annually. Refer to the website for detail information.

The Fulbright-Fogarty Fellowships in Public Health are offered through a partnership between the Fulbright Program and the Fogarty International Center of the U.S. National Institutes of Health. These awards were established to promote the expansion of research in public health and clinical research in resource-limited settings. Fulbright-Fogarty Fellowships carry the same benefits as the traditional Fulbright Study/Research grants to the host country. The Fogarty International Center, NIH, will provide support to the research training site and may provide orientation for the fellows at the NIH.

The Fulbright-Fogarty Fellowships in Public Health are offered through a partnership between the Fulbright Program and the Fogarty International Center of the U.S. National Institutes of Health. These awards were established to promote the expansion of research in public health and clinical research in resource-limited settings. Fulbright-Fogarty Fellowships carry the same benefits as the traditional Fulbright Study/Research grants to the host country. The Fogarty International Center, NIH, will provide support to the research training site and may provide orientation for the fellows at the NIH.

Application Deadline: 15 September 2025 The main focus of the award is to foster collaborative research activities with the University. That would be done mainly by developing ideas for collaborative research initiatives aimed at the European Union and/or U.S. funding organizations incorporating her/his specific expertise into the projects. It would be expected that the award will participate in research seminars on topics of her/his expertise, and collaborate as a member of the team on research writing. The group at the University of Murcia has active ongoing collaborations with the Harvard T.H. Chan School of Public Health, Icahn School of Medicine at Mount Sinai, and Washington State University. The scholar should have experience in research grant writing. SCHOLARS SELECTED FOR THIS AWARD WILL BE REQUIRED TO Participate in collaborative research initiatives directed to European Union and/or U.S. funding organizations. Give two research seminars on a topic of his/her choice. Collaborate in ongoing research projects at the University. Research The main areas of ongoing research at the University are environmental health epidemiology and reproductive health epidemiology. The University is also currently developing new research on hospital epidemiology, including clinical epidemiology, and infectious disease epidemiology. The award would be expected to collaborate in any (or both) of the research areas.

The Global Health Innovative Technology Fund (GHIT Fund) established a Drug Discovery Screening Platform in early 2013 to facilitate the screening of compound libraries for identification of novel compounds for malaria, tuberculosis, Chagas disease and leishmaniasis. The goal is to leverage the active screening programs of established Product Development Partnerships (PDPs) and the relevant compound libraries from Japanese companies or academic institutions. The expectation is that the Japanese entity will provide its relevant compound libraries to their PDP partner, who will then conduct screening with support from their established screening organization network. The GHIT Fund will reimburse for screening project costs. Following the COVID-19 pandemic, the GHIT Fund has expanded its disease scope by adding selected Emerging and Re-Emerging Infectious Diseases for the Screening Platform. DEADLINE: 7/4/2026

The Global Health Emerging Scholars (GHES) program is a 12-month mentored global health research training fellowship at select institutions in low-and-middle-income countries (LMIC). The GHES program was established in 2012 and is comprised of four US partner institutions – Yale University, the University of California at Berkeley, Stanford University, and the University of Arizona – that together have collaborations in 16 LMICs representing Africa, Latin America, the Caribbean, South and Southeast Asia, the Middle East, Eastern Europe, and Oceania. The program is designed for pre- and post-doctoral trainees from the U.S. and post-doctoral trainees from collaborating LMICs who are dedicated to pursuing a career in global health and want to gain a solid scientific research foundation in a collaborative environment to develop into productive, independent researchers in global health. GHES offers hand-on opportunities to conduct research projects relevant to the health priorities of stakeholders and partners at established medical and research institutions and project sites in collaborating LMICs while being mentored by dedicated experts. DEADLINE FOR APPLICATION: October 1, 2025 at 5:00pm Eastern Time.

Usually application due in November; application opens in August. The Global Health Fellowship Program is a 12-month clinical research training program for post-doctorate trainees and doctoral students in the health professions, sponsored by the NIH’s Fogarty International Center (FIC) in partnership with several NIH Institutes and Centers.

ASTMH offers a variety of fellowships and awards for members and, in some instances, non-members, and Early- and Mid-Career Professionals. To support the professional growth of early- and mid-career professionals, the Society offers the Benjamin H. Kean Travel Fellowship in Tropical Medicine, Burroughs Wellcome Fund/ASTMH Postdoctoral Fellowship in Tropical Infectious Diseases, Centennial Travel Award in Basic Science Tropical Disease Research and the Robert E. Shope International Fellowship in Infectious Diseases. See the URL for criteria and deadlines.

The Africa Open Lab is inviting applications from African scientists at an early stage of their career with an interest in conducting research in infectious diseases. We strive to enable awardees to develop their research careers through offering funding for a research project and mentoring while they conduct their innovative research projects.

THIS CALL IS LED EVERY 2 YEARS. NEXT CALL WILL BE IN APRIL 2027. The biennial EDCTP Prizes recognise outstanding individuals and research teams from Africa and Europe who have made significant achievements in their research field. Additionally, the awardees will have made major contributions to strengthening clinical research capacity in Africa and supporting South-South and North-South networking. The following prizes are available: Dr Pascoal Mocumbi Prize (€50,000) The Dr Pascoal Mocumbi Prize aims to reward an individual in recognition of his/her outstanding achievements in advancing health research and capacity development in Africa with significant impact on the wellbeing of the African population. Outstanding Research Team Prize (€50,000) This prize is awarded to outstanding research teams in sub-Saharan Africa and Europe working on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases. Outstanding Female Scientist prize (€20,000) The prize is awarded to female scientists who have made a significant scientific contribution and built measurable impactful research capacity through training and mentorship for the future generation of researchers/scientists in Africa. Four Scientific Leadership Prizes (€15,000 each) Two Scientific Leadership Prizes (one woman and one man) for researchers who are permanent residents of an EU Member State or a country associated with the Horizon Europe programme.

APPLICATION DEADLINE: 18 August, 2025 The GBD Fellowship is an early-career training program that provides opportunities for interdisciplinary research in health metrics to individuals with a doctorate degree or equivalent (PhD, MD, DPhil, MBBS). This program combines academic research, education and training, and professional work with mentoring from IHME faculty and researchers. The purpose of the Fellowship is to enhance an individual’s skills in conducting and leading in-depth methodological research on a variety of health metrics topics. The GBD Fellowship is a cohort-based program focused on bringing together a diverse cadre of talented researchers. This program provides a unique opportunity for Fellows to collaboratively exchange their expertise and insights, thereby enriching the collective knowledge base and advancing health metrics research. Refer to the website for detail information.

Application Deadline: 1 September 2025 These support antimicrobial research in low- to middle-income countries. Projects should address one of the following areas: • What are feasible and effective prevention strategies to prevent transmission of (resistant) pathogens in low resource settings? • What basic laboratory support does a healthcare system minimally need to tackle infectious diseases? • How do we improve antimicrobial use worldwide to ensure it is delivered only to those who need it? Funding amount is 15,000 pounds

Global Health Travel Awards (for the Global Health Series) are to enable attendance of scientists, physicians, fellows or students from countries where the meeting topic health problems are endemic. The purpose of providing travel awards is to add to the diversity of experiences represented by participants at each meeting. The award will cover conference-related expenses to include: meeting registration, lodging, airfare and ground transportation from host airport to the resort. The amount of the awards will vary, depending on where awardees are coming from and the extent of their need.

This Notice of Funding Opportunity (NOFO) invites eligible academic or research institutions to apply for funding support to purchase latest scientific equipment that will enhance and modernize research-supporting operations of existing shared biomedical research facilities. Targeted are laboratory research core facilities, animal research facilities, and other similar shared-use research spaces. The goal of this NOFO is to strengthen research-auxiliary activities of biomedical research facilities and to enhance the efficiency of their operations. The NOFO does not support the purchase of scientific research instruments or their components, nor components of building-level infrastructure equipment that indirectly support research activities.

Applications for the third round of the New York State Biodefense Commercialization Fund are now closed. Please check back for updates on the program. The $40 million Biodefense Commercialization Fund was created to encourage and accelerate the development and commercialization of solutions for serious infectious disease threats, including COVID-19 and its variants, while fostering the creation of new life science businesses and supporting industry growth. The Fund has offered grants to startup companies and academic institutions that are developing promising diagnostics, vaccines, therapeutics, and such other innovations as epidemiological surveillance tools, environmental controls, and clinical care advances that address or mitigate infectious disease threats. For the current application period, New York State seeks applications focusing on the specific areas of interest: - Novel platforms for development of rapid Point-of-Care (POC) diagnostics (examples include, but are not limited to, CRISPR and/or Isothermal-based platforms) with priority given to POC diagnostics that can perform as well as or better than existing lab tests. - Processes that integrate easy-to-use sample preparation and allow for access in low resourced settings. - Novel tools for sequencing and serology-based tests that support infectious disease and pathogen surveillance

NIH NIAID - Grants and Fundings - Searchable Database

The National Institute on Drug Abuse (NIDA) seeks collaborative research by multi-disciplinary teams to address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, medications development, health services, HIV/AIDS and co-occurring opportunistic infections (e.g., viral hepatitis C, tuberculosis, sexually transmitted infections) and associated consequences in people who use or misuse substances or have a substance use disorder, or other research areas relevant to substance use, misuse, or use disorders. NEXT SUBMISSION DEADLINE: 9/7/2025

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant. All applications must be within the scope of the mission of one of the Institutes/Centers listed in the notice. Application DEADLINE: Multiple dates, see announcement.

Contact: Robert Mahon Robert.Mahon@nih.gov Objective: The scientific objectives of this new initiative are to 1) better understand the types and pathogenesis of long-term lung damage resulting from pulmonary tuberculosis (TB) and the role of the host immune response, and 2) identify ways to mitigate lung damage during TB treatment through host-directed therapy. There is no set-aside funding for this NOSI.

The Calmette & Yersin Programme internship grants aim to support Pasteur Network scientists, whether they are students, technicians, engineers or researchers to carry out an internship within the network. The purpose of the internship os to reinforce the intern's skills in his/her field of research and to reinforce the capacities of the institute of origin. Any subject covered by a Pasteur Network institute laboratory: research into infectious diseases (infectious physiopathology, immunology, microbiology, epidemiology, virology, parasitology) and public health activities (diagnosis, monitoring, resistance, etc.). It must be consistent with the candidate's research area. Calendar for 2025 Selection: 5th of March 20th of June (deadline extended) 17th of September 10th of December

Expiration Date: 6 September 2025 This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Notice of Funding Opportunity requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH and CDC Institutes and Centers (ICs) based on their scientific missions.

Applications are now being accepted and reviewed on a rolling basis. There is no deadline to apply! The Public Health Laboratory Fellowship Program aims to strengthen laboratory systems and workforce needs by developing the next generation of public health scientists! Thus, the fellowship program will focus on training participants in alignment with established laboratory core competencies and offer experiential learning opportunities across laboratory science focus areas. Fellowship terms are one year, with a possible extension for a second year, depending on the fellowship and funding availability. ​​ APHL offers flexible start dates to meet fellow's and mentor's needs. ​ Fellows will work on projects specific to a laboratory science focus area that will support public health, One Health, and other initiatives. Below are examples of the different focus areas fellows could be matched with and placed into: Bioinformati​​​cs​ Biorisk Management Emergency Preparedness and Response Environmental Health Food Safety Infectious Disease Informatics Laboratory Operations and Support Services Quality Management Radiochemistry Ronald H. Laessig Newborn Screening​ Fellows are placed in host laboratories which include state and local public health laboratories and non-federal academic, agricultural, chemical, environmental, food safety and veterinary laboratories. Regardless of host laboratory type, the fellow will still be trained in techniques and competencies that are transferrable to a career in public health laboratory science.

Deadline: 1 September 2025 The SAMRC is now pleased to launch this request for applications (RFA) to support researchers with active/previously active U.S. funded grants that were affected by the funding cuts, based at South African public universities and South African public research entities. Applicants may apply for funding support for up to 12 months to continue, wind down or complete critical research activities and sustain the projects until U.S. funding is resumed or alternative funds are sourced. Importantly, this RFA does not seek to fund new research projects or to fully replace the original funding awards. It is intended to provide immediate bridging support to enable continuity of critical research, sustain key personnel and infrastructure and support post-doctoral studies interrupted by the U.S. funding cuts.

Closing date: 22 September 2025 The main objectives of this funding instrument are to: Support promising clinicians who want to obtain doctoral qualifications while retaining their employment or clinical duties. Assist institutions in developing innovative and effective dual-training pathways, which provide the opportunity for PhD-level research alongside the conventional clinical training track. The award is designed to offer flexible and realistic options to clinicians who want to pursue their PhD studies. It may be used to provide protected research time from clinical training or clinical service obligations to support PhD studies undertaken in parallel with clinical activities. The use of funds is strictly for research training, i.e., obtaining a PhD. SAMRC priority research areas: Biomedical Research HIV, TB and other communicable diseases Health System Strengthening Health Promotion and Disease Prevention Maternal, child and woman health Non-communicable diseases Public Health Innovation Violence, injury and trauma

Application Deadline: 30 September 2025 The Foundation is seeking highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field. All applications must be approved by the University Provost or the Vice President of Research, and should be submitted through the office of sponsored research or like office that provides institutional approval for the request. Studies selected through an internal competition are preferred. Applications submitted by an individual researcher will NOT be considered." Please refer to the link below for more specific information on this RFP.

Through the RACP Foundation, there is financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships, scholarships and grants are available annually, totalling over $2.5 million in funding. All applications across the different award categories will be assessed by review panels comprised of members of the Grants Advisory Committee, representatives from partner organisations, RACP Divisions, Faculties and Chapters, and other invited peer reviewers.

SANTHE supports innovative research projects, trainee fellowships, collaborations, leadership development, community and public engagement, and diversity and inclusion in science.

The SAMRC’s vision is to build a healthy nation through research and innovation. For this vision to be realised, health researchers (locally and internationally) need funding to access the necessary resources and facilities. While the SAMRC funds many internal and external research projects itself, as well as in collaboration with partnering institutions, it also connects innovative researchers with like-minded organisations across the world that provide funding opportunities.

TDR supports effective and innovative global health research, through strengthening the research capacity of disease-affected countries, and promoting the translation of evidence into interventions that reduce the burden of infectious diseases and build resilience in the most vulnerable populations

APPLICATION DEADLINE: 15 September, 20025 This new fellowship programme will maximize the value of the clinical research skills obtained through the placement at a TPO by focusing on research leadership, with fellows using their clinical research skills, in conjunction with competencies and capabilities to effectively communicate with, and support, members of a multidisciplinary team. Every effort will be made to support the participation of women, notably in building on learnings from former fellows and institutional development plan will enable the fellows to maximize their contribution to strengthening their institution on re-entry and develop and manage a research team to undertake a research study. Fellowships are anticipated to greatly contribute to the advancement of top and promising researchers, enhancing their impact on the improvement of research institutions in low- and middle-income countries (LMICs), including the facilitation of peer training. TDR will fund fellows employed by academic and research institutions in any low- and middle-income country across the globe (not limited to those in sub-Saharan Africa) to be placed in pharmaceutical companies, product development partnerships (PDPs) and academic-affiliated research organizations, in Africa, America, Asia, Europe and Latin America, to train and develop new research skills on infectious diseases. Successful applicants are placed from 6 to 12 months in TPOs and receive a reintegration plan for 12 months at their home institutions. Fellowship duration will be based on the proposed targeted training offered by each TPO.

The Antibacterial Resistance Leadership Group (ARLG) invites requests for industry collaboration from the ARLG in the form of advice, guidance, protocol design for drug, device, or diagnostic development. The ARLG develops, designs, implements, and manages a clinical research agenda to increase knowledge of antibacterial resistance (AR). The ARLG aims to advance research by building transformational trials that will change clinical practice and reduce the impact of antibacterial resistance and antimicrobial resistance through the following strategies: - Early clinical evaluation of new antibacterials; - Comparative effectiveness or efficacy trials; - Strategy trials to optimize currently licensed antibacterials (dose, duration, need for drug) to reduce the risk of resistance; - Clinical algorithm testing strategies; - Treatment-based prevention measures; - Diagnostics testing in the context of treatment trials, epidemiologic elements, or behavioral modification; - Effective infection control programs which include surveillance for resistant organisms, outbreak investigation, and antibiotic stewardship to prevent the development and spread of resistant organisms; - Novel facilities level activities to prevent the development of resistance.

Deadline: 10 September 2025 This scheme is for outstanding scientists who are in the early stages of their research career and have the potential to become leaders in their field. These long-term fellowships provide the opportunity and freedom to build an independent research career in the UK or Republic of Ireland and pursue cutting-edge scientific research. The fellowship covers following research areas: Ai: Astronomy, cosmology, physics, earth sciences, environmental physical sciences & geosciences Aii: Chemistry and engineering Aiii: Pure and applied mathematics, computer science, statistics, communications and computer engineering; the mathematical aspects of astronomy, physics, cosmology, gravitation, theoretical physics Bi: Molecular and cellular biology, zoology, plant sciences and physiology Bii: Biomedical Sciences  

The purpose of this program is to encourage the development of researchers in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The goal is to fund applicants who will go on to be independent investigators. The Fund will make up to 32 awards total with two funding cycles (16 awards each).

Offers funding and support across all academic disciplines and industrial areas from the medical and biological sciences to astronomy, physics, chemistry and engineering, social sciences, economics, environmental sciences, and the arts and humanities.

Unitaid supports in making new health products available and affordable for people in low- and middle-income countries. It identifies innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast. It provides health partners with financial grants to accelerate innovation in global health.

The VALIDATE Network aims to accelerate vaccine research and development for three groups of complex neglected intracellular pathogens that cause significant mortality and morbidity throughout the world, particularly in low-and-middle-income countries (LMICs): Mycobacteria (causing tuberculosis, leprosy and other diseases), Leishmania (causing leishmaniasis) and Burkholderia pseudomallei (causing melioidosis). A second, important aim of the VALIDATE Network is to facilitate career progression for its members, particularly Early Career Researchers (ECRs), and (recognising career progression inequity) researchers from LMICs and researchers identifying as female and/or non-binary. CALL FOR ROUND 6 AWARDS IS EXPECTED IN DECEMBER 2025

Application deadline: 20 November 2025 This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing. Please refer to the website for details

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. The applications are opened 3 times a year

Wellcome - Grants and Fundings - Searchable Database

DEADLINE: 25 August, 2025 Must create supplier account to access the RFP